Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2014; 20(18): 5302-5307
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5302
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5302
Name of therapy | Time (d) | Contents of therapy |
Triple therapy | 7-14 | Proton pump inhibitor (PPI) (twice daily) + clarithromycin (500 mg twice daily) + amoxicillin (1 g twice daily) or metronidazole (500 mg twice daily) |
Quadruple therapy | 10-14 | PPI (twice daily) + bismuth subsalicylate (525 mg 4 times daily) + metronidazole (250 mg 4 times daily) + tetracycline (500 mg 4 times daily) |
Levofloxacin therapy | 7-10 | PPI (twice daily) + levofloxacin (250 mg twice daily) + amoxicillin (1 g twice daily) |
Sequential therapy | 10 | PPI (twice daily) + amoxicillin (1 g twice daily) for the first 5 d, followed by PPI + clarithromycin (500 mg twice daily) + nitroimidazole/tinidazole (500 mg twice daily) |
Concomitant therapy | PPI (twice daily) + amoxicillin (1 g twice daily) + clarithromycin (500 mg twice daily) + metronidazole | |
Levofloxacin-containing sequential therapy | 10 | PPI +amoxicillin (1 g twice daily) for the first 5 d followed by PPI + levofloxacin (500 mg daily) + metronidazole (500 mg twice daily) |
-
Citation: Alahdab YO, Kalayci C.
Helicobacter pylori : Management in 2013. World J Gastroenterol 2014; 20(18): 5302-5307 - URL: https://www.wjgnet.com/1007-9327/full/v20/i18/5302.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i18.5302